EPHA2 and familial pancreatic carcinoma: TheEphA2-EV nPES assay demonstrated high diagnostic accuracy, effectivelydistinguishing pancreatic cancer from pancreatitis and healthy controls.Furthermore, EphA2-EV levels correlated with tumor progression andearly treatment responses, outperforming conventional ELISA.